Aceragen’s Final Chapter: Liquidation Process Underway
The biopharmaceutical company Aceragen has formally entered liquidation following the cessation of its business operations. Stakeholders are now awaiting specifics on the distribution of remaining funds as the company’s assets are sold off. Aceragen has effectively ceased to exist as a publicly traded entity. Trading on major exchanges has been permanently halted as the company…

